ERNA vs MTD · P/E 0.0, rev $582.0K vs P/E 27, rev $3.87B
Eterna Therapeutics Inc (ERNA) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the ERNA and MTD stock pages for the full models.
Not investment advice.